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Abstract
The Geostationary Operational Environmental Satellite (GOES-7) pro-
vides high-quality environmental data about the temporal development and
energy characteristics of the protons emitted during a solar particle event.
The GOES-7 time history of the hourly averaged integral proton flux for var-
ious particle kinetic energies are analyzed for the solar proton event occurring
October 19 29, 1989. This event is similar to the August 1972 event that has
been widely studied to estimate free-space and planetary radiation-protection
requirements. By analyzing the time-history data, the dose rates, which can
vary over many orders of magnitude in the early phases of the flare, can
be estimated as well as the cumulative dose as a function of time. When
basic transport results are coupled with detailed body organ thickness distri-
butions calculated with the Computerized Anatomical Man and Computerized
Anatomical Female models, the dose rates and cumulative doses to specific
organs can be predicted. With these results, the risks of cancer incidence
and mortality are estimated for astronauts in free space protected by various
water shield thicknesses.
Introduction
Once outside the Earth's protective magneto-
sphere, a crew on a lunar or Mars mission will en-
counter a harsh free-space radiation environment in-
cluding galactic cosmic rays and solar flare protons.
The October 1989 flare is typical of the rarely occur-
ring large flares, while the smaller normally occurring
flares are much less hazardous. Galactic cosmic rays
(CCR) are also a source of exposure characterized by
a much lower but continuous dose rate. The contri-
bution to dose from GCR becomes more important as
mission duration increases. This study investigates
the high dose rate delivered by a typical large flare
that can be mission threatening if crew members are
unable to retreat to sufficiently shielded areas. Early
or acute effects from such a large dose can include
blood count changes, vomiting, and possibly death.
In addition, the crew and mission planners must also
consider the delayed or late effects of excessive radi-
ation exposure. Several late biological effects to con-
sider are the risk of cancer induction and mortality,
the risk of cataract induction, and the risk of infer-
tility. Dose estimates to critical body organs can be
estimated by analyzing flare transport and dosimetry
calculations in conjunction with anatomical thickness
distributions to assess possible health effects.
The potential exposure of critical body organs is
evaluated for the 1989 October proton event. Six sig-
nificant flares that occurred from August to Novem-
ber 1989 have been recorded by the Geostation-
ary Operational Environmental Satellite (GOES-7).
GOES-7 is a weather satellite in geostationary or-
bit above 75°W and is operated by the National
Oceanic and Atmospheric Administration (NOAA).
The GOES-7 also monitors the temporal develop-
ment and energy characteristics of protons emitted
during solar particle events. Of the six 1989 flares
recorded, the flare occurring October 19 29 had the
largest free-space dose potential. The high-quality
environmental data from GOES-7 allow a more de-
tailed study of the recent flares compared with ear-
lier flare events, such as the widely studied Febru-
ary 1956, November 1960, and August 1972 events.
Details on the measurements of flare characteristics
of earlier solar cycles (XIX to XXI) have been docu-
mented (refs. 1 and 2). Figure 1 compares the proton
fluence energy spectra of the four large events. As il-
lustrated, the October 1989 flare is on the order of
the large August 1972 event.
The scope of this paper focuses on the time his-
tory of the October 1989 proton event. Potential dose
rates and cumulative doses are estimated for criti-
cal body organs of astronauts protected by varying
amounts of shielding. This paper assesses excess life-
time risks of cancer incidence and mortality as well
as possible early health effects.
Symbols
D
E
F
H
J
Q
R
dose, Gy or cGy
energy, MeV
integral flux, protons/cm2-sec-sr
dose equivalent, Sv or cSv
integral fluence, particles/cm 2
quality factor
rigidity
RISK riskof cancerincidenceormortality
per1000population
S stopping power, MeV/cm
t thickness, cm
x distance, cm
# total nuclear cross section, cm -1
a differential interaction cross section,
cm-l_MeV -1
¢ differental flux, particles/cm2-sec -
MeV
Nomenclature
blood-forming organ
a baryon transport code
Computerized Anatomical Female
Computerized Anatomical Man
extravehicular activity
galactic cosmic rays
Geostationary Operational Environ-
mental Satellite
1.0 Gy = 100 rad, 1 cGy = 1 rad
high charge and energy
International Commission on
Radiological Protection
ICRU International Commission on
Radiation Units and Measurements
LET linear energy transfer
LEO low-Earth orbit
NCRP National Council on Radiation
Protection and Measurement
NOAA National Oceanic and Atmospheric
Administration
Sievert 1.0 Sv = 100 rem, 1 cSv = 1 rem
Radiation Exposure
Currently dose limits are not established for ex-
ploratory class missions; however, it is recommended
that limits established for low-Earth-orbit operations
be used as guidelines (ref. 3). These limits are es-
tablished by the National Council on Radiation Pro-
tection and Measurement (NCRP) and include dose
limits for the skin, ocular lens, and vital organs as
BFO
BRYNTRN
CAF
CAM
EVA
GCR
GOES-7
Gray
HZE
ICRP
shown in table 1 (ref. 3). For high-energy radiation
from solar proton flares, the dose delivered to the
vital organs is important with regard to latent car-
cinogenic effects and is often referred to as the blood-
forming-organ (BFO) dose. The doses incurred dur-
ing a proton flare will include a high linear energy
transfer (LET) component through the production
of nuclear reaction products in tissue. The biological
effects of these HZE (high charge and energy) parti-
cles are not well understood and lead to uncertainty
in risk estimates (refs. 3 and 4). Dose-equivalent lim-
its for carcinogenic and mutagenic effects are estab-
lished for short-term (30-day) exposures, annual ex-
posures, and total career exposures. These values are
listed in table 1. The short-term (30-day) exposures
are important when considering solar flare events be-
cause of their high dose rate. It is believed that by
adhering to the short-term limits, nonstochastic late
effects as well as acute effects of tile bone marrow,
ocular lens, and skin can be held to acceptable levels
(ref. 3).
Table 1. Ionizing Radiation-Exposure Limits for
Space Station Freedom Astronauts
[Data from NCRP-98 (ref. 3)]
Dose equivalent, cSv
Exposure
interval
30 day
Annual
Career
Blood-forming
organ
25
50
100-.400 a
Ocular
lens Skin
100 150
200 300
400 600
aVaries with gender and age at initial exposure, see
table 2.
Total career exposure limits for the BFO are
determined by the gender of the individual and the
age at the time of initial exposure (table 2). To
estimate exposure limits for ages other than those
shown in table 2, an approximate linear relationship
(ref. 3) exists as follows:
For males Limit = 2 + 0.075 (Age - 30) Sv
For females . Limit = 2 + 0.075 (Age - 38) Sv
The recommended career limits are based on a 3-
percent lifetime excess risk of fatal cancer from in-
duced tumors. An excess 3-percent lifetime risk can
be compared with the "naturally" occurring risk of
fatal cancer, which is approximately 18 percent for
males and 15 percent for females (ref. 3).
Table2.CareerDose-EquivalentLimitsforaLifetime
ExcessRiskofFatalCancer of 3 Percent as a
Function of Age at Exposure
[Data from NCRP-98 (ref. 3)]
BFO dose-equivalent, cSv, limit for first
exposure at an age of--
Gender 25 yr 35 yr 45 yr 50 yr
Male
Female
150
100
250 325
175 250
400
300
Acute effects, such as radiation sickness or death,
are manifested by direct energy deposition. If a
1.5 to 2.0 Gy whole-body dose were incurred in a
short time period, an individual would have a 50-
percent chance of prodromal vomiting within 2 days.
Vomiting, which is especially serious for a helmeted
individual, has an estimated effective threshold of
1 Gy. If a 3.2 to 5.4 Gy whole-body dose were
incurred in a short time period, an individual with
minimal to supportive medical care would have a
50-percent chance of death within 20 to 40 days.
(See ref. 3.) The estimated effective threshold for
mortality is 1.5 Cy.
Of the ocular tissues, the lens of the eye is the
most susceptible to radiation-induced damage. Dam-
age to other ocular tissues, which have estimated
threshold doses on the order of 10 to 20 Gy, seems
unlikely to exhibit tissue damage of clinical signifi-
cance during space travel (ref. 3). The opacification
of the lens or formation of cataracts has a signif-
icantly lower threshold dose, with a single dose of
approximately 1 to 2 Gy causing minimal stationary
opacities (ref. 3).
Large solar proton events have the potential to
deliver significant doses to the skin. One effect
of such an acute exposure is erythema and moist
desquamation, or reddening of the skin (similar to
a severe sunburn) and blister formation (second-
degree burns). A dose of approximately 6 Gy causes
erythema in 50 percent of individuals, while the
more serious moist desquamation requires a dose
of approximately 20 Gy for a 50-percent response.
Late effects to the skin, which can appear months to
years later and can occur without evidence of early
acute reaction, can include vascular damage, dermal
fibrosis, and atrophy of the epidermis and dermis
(ref. 3).
Fertility, although not a life-threatening effect,
can be a major concern to crew members. Sensitivity
to radiation-induced sterility varies with age. Women
over 40 years old are more susceptible to radiation-
induced menopause than younger women. Doses
greater than approximately 1 Gy to the ovaries can
produce transient sterility for a few months, while
doses less than 1 Gy are unlikely to have any long-
term effects on sterility (ref. 3). Smaller doses are
required for transient male sterility. A single 0.15 Gy
acute dose to the testes significantly lowers the sperm
count of 40 percent of males within approximately
2 months. Doses of 0.3 Gy to 0.5 Gy can result
in decreased sperm count and temporary sterility
lasting between 10 to 20 months, with doses up to
4 Gy causing temporary sterility or infertility for up
to 30 months (ref. 2).
Computerized Anatomical Models
Estimates of specific dose and dose equivalent to
the skin, ocular lens, and blood-forming organs are
calculated through use of the Computerized Anatom-
ical Man (CAM) model (ref. 5). These doses are com-
pared with the frequently used slab-dose estimates to
determine the quantitative differences resulting from
the use of the detailed model. When detailed body
geometry is not considered, the BFO dose is usually
computed as the slab dose at a 5-cm depth in tis-
sue. The skin dose can be approximated by a 0.1-cm-
depth dose, and the ocular lens dose can be approx-
imated by a 0.3-cm-depth dose. Typically to further
simplify dose and shielding estimates, a 0-cm-depth
dose for both the skin and the ocular lens can be
conservatively used.
The CAM model used to calculate the shielding
influence of the human body geometry is based on the
fiftieth percentile United States Air Force male in the
standing position. Each tissue thickness distribution
surrounding a given point within the body is calcu-
lated with an evenly spaced distribution of 512 rays
over a solid angle of 4_r. For example, for each of
the 512 rays emanating from a specific location in
an organ, the equivalent thickness of water traversed
based on organ, bone, and other constituent densities
encountered before exiting the body are calculated.
The Computerized Anatomical Female (CAF) model
uses a 0.92 scale factor to the CAM model and in-
corporates the female reproductive organs (ref. 6).
The thickness distributions derived from the
CAM and CAF models (figs. 2 to 9) are used to esti-
mate potential doses from the October 1989 event.
The skin, ocular lens, and BFO distributions are
plotted in figure 2 as percent thickness less than t
versus t. These distributions are used in a manner
analogous to a cumulative probability distribution
function of the thickness traversed in every direction
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abouta givenpoint. The skinand BFO distribu-
tionsareeachaveragesof 33 locationswithin the
humanbodymodel,while the ocularlensdistribu-
tionisapproximatedbyasinglereferencepoint.The
BFOlocationsincludepointswithin thepelvis,hip,
humerus,sternum,femur,fibula,andotherareasof
bonemarrowproduction.
The dosesto variousother organssuchas the
thyroid, lung, esophagus,tomach,intestine,liver,
pancreas,kidney, bladder, testes,ovary, uterus,
and breastcan alsobe calculatedthroughuseof
computer-generatedthicknessdistributions. Both
the CAM and CAF thyroid distributionsareaver-
agesof fourdistributionscalculatedat separateref-
erencepoints within the thyroid. The directional-
ity dependenceofthethicknessdistributionis main-
tainedduringthe averagingprocess,wherefor each
of the 512directions,the averagethicknessin the
particulardirectionisdetermined.Theresultingav-
eragethicknessesarethenarrangedinto thepercent
thicknesslessthan t versus t form for illustration.
Figure 3 shows the distribution of each of the se-
lected points for the CAM thyroid, with the dashed
line representing the average of the distributions.
The average CAM and CAF thyroid distributions are
compared in figure 4. With the CAM thickness distri-
bution greater at most depths, the effects of the CAF
0.92 scale factor are apparent. All other internal or-
gan distributions, with the exception of the stomach,
right lung, and breast, arc evaluated at a single point.
The stomach and right lung distributions represent
averages of five locations, while the breast represents
an average of four locations. Distributions associ-
ated with the digestive system are shown in figure 5.
The pancreas and liver distributions are very similar
(fig. 6); thus, the predicted doses are expected to be
comparable. On the other hand, the dose estimates
are expected to be much greater for the testes than
for the kidney because of the large differences in their
distributions (fig. 7). The CAF distributions for sev-
eral female organs are included in figures 8 and 9. Po-
tential doses to the various organs can be estimated
by using each of these thickness distributions in con-
junction with dose-depth curves calculated for the
October 1989 event.
Analysis of Flare Data
The time history of the integral proton flux for
various particle kinetic energy values is shown in
figure 10 for the 10-day period beginning at 00:00
UTC (Coordinated Universal Time) on October 19,
1989. These data are hourly averaged flux values
recorded by the GOES-7 proton monitor (ref. 7). As
shown in figure 10, three major pulses of high-energy
protons arrived at the satellite during this event. In
addition, a strong magnetic disturbance during the
first pulse (_12 hours after the initial flux increase)
caused flux levels at all energies shown to increase by
factors of 5 or more for 4 to 5 hours.
To use the satellite data in the baryon transport
code BRYNTRN (ref. 8) developed at NASA Langley
Research Center, the integral fluxes at a given time
are interpolated and extrapolated to the code energy
grid points according to the usual rigidity parame-
terization:
where F is the integral flux, F0 and R0 are curve-fit
parameters, and R is the rigidity:
R = [E 2 + 2(938.26)E] 1/_
for energy E in units of MeV. The integral fluxes
at the desired grid energies are then numerically dif-
ferentiated to obtain the differential fluxes required
for the transport calculations. This procedure is
performed for various time values during the event.
These _ime values are selected to reasonably charac-
terize the temporal flux behavior (i.e., times corre-
sponding to maximum and minimum flux values and
times intermediate to where the extrema occur). A
table listing the integral fluxes at each energy value
for the 14 times chosen during the episode (ref. 7) is
included in the appendix.
Another useful display of the data that illustrates
the time-development of the flare is given in figure 11,
which gives the differential fluences at successive
times during the event. As shown in figure 11, a large
fraction of the proton flux is encountered by day 2
of the data period. For purposes of this analysis, the
event is assumed to be over at day 10.
Transport and Dosimetry Calculations
Once the differential fluxes at each time value are
obtained from the raw data, the nucleon transport
computer code BRYNTRN (ref. 8) is used to predict
the propagation and interactions of nucleons through
various media. The code uses an algorithm that
provides solutions to the Boltzmann equation in the
one-dimensional, or "straight ahead," approximation
form:
[0Ox o ]OE Sj(E)+#j(E) Cj(x, E)
= ajk(E , E') Ck(x, E') dE'
where the quantity to be evaluated, Cj(x, E), is
the flux of particles of type j (protons or neutrons)
having energy E at spatial location x. The solu-
tion methodology of this integrodifferential equation
can be described as a combined analytical-numerical
technique (ref. 9). The accuracy of this numeri-
cal method has been determined to be within ap-
proximately 1 percent of exact benchmark solutions
(ref. 10). The data required for solution consist of
the stopping power Sj in various media, the macro-
scopic total nuclear cross sections #j, and the dif-
ferential nuclear interaction cross sections ajk. The
differential cross sections describe the production of
type j particles with energy E by type k particles
of energy E'. Detailed information on these data
base compilations is described in reference 8. Salient
features of this code and its implementation are de-
scribed in references 8, 11, and 12.
Once the particle fluxes are determined, the ab-
sorbed dose (in units of Gy) can be computed. The
absorbed dose due to energy deposition at a given
location by all particles can then be related to bio-
logical risk by introducing the quality factor Q, as
specified by the International Commission on Radi-
ological Protection (ICRP). (See ref. 13.) Thus, the
values of dose equivalent H (in units of Sv) used to
specify radiation exposure are computed as follows:
//H(x) = _ Qj(E) Sj(E) Cj(x, E) dE
)
These values can be compared with the radiation-
exposure limits of table 1. Using the previous ap-
proach, the dose and dose equivalent versus depth in
water for each of the 14 time values are calculated
from the hourly averaged flux.
For the October 1989 flare analysis, transport cal-
culations and corresponding dose-equivalent evalu-
ations are made for normally incident particles on
slabs of water as the attenuating medium. Such an
approach necessarily invokes the straight-ahead ap-
proximation that has been shown to slightly over-
estimate the actual exposure for space radiations
(ref. 14). Water is selected for all CAM and CAF
thicknesses because it provides a good simulation of
human tissue with regard to ionizing radiation trans-
port. For shield thicknesses, the dose calculations
for water can often provide good estimates for equiv-
alent thicknesses of organic and organic-composite
materials. The shield density thickness (g/cm 2) re-
quirements for aluminum and other higher atomic
numbered materials are greater. The October 1989
flare spectrum is relatively deficient in high-energy
particles; therefore, for the shield thicknesses consid-
ered in this study (0.5, 2.0, 5.0, and 10.0 g/cm2), the
estimated doses behind effective shield thicknesses of
aluminum are approximately 25 to 30 percent greater
than the estimated doses behind corresponding water
shield thicknesses (ref. 15).
The dose-depth functions shown in figure 12
compare the present 10-day time-integrated results
computed with the ICRP-26 quality factors with
corresponding calculations using the integral fluence
rigidity function of reference 7 for both ICRP-26 and
ICRU-40 quality factors (ref. 16). Even more re-
cently, quality factors have been recommended by
ICRP-60 (ref. 17). Neither the ICRU-40 nor the
ICRP-60 has as yet been accepted by any regu-
latory body in the United States. The ICRU-40
dose-equivalent calculations are comparable with the
ICRP-60 calculations for the October 1989 event.
While the change in quality factors from ICRP-26
does not significantly affect the dose equivalents for
solar proton flares of this type, larger differences are
seen for the contributions to dose equivalent from the
HZE particles of GCR. The integral fluence rigidity
function reported by NOAA (ref. 7) is
with J0 equal to 1.12 x 1011 particles/cm 2 and R0 =
77.4 MV. The differences due to the two quality fac-
tors are relatively small (_5-10 percent, with larger
differences occurring at smaller thickness values).
Differences between the fluence rigidity-fit values and
the time-integrated values are more prominent, par-
ticularly at greater thicknesses (15 30 g/cm 2) for
which the present results exceed the functional-fit
results by 25 to 50 percent. This difference can be
explained by the differences in the time-integrated
and fluence-fit spectra shown in figure 13. At ener-
gies greater than 100 MeV, the present results exhibit
higher particle fluence than the fluence-fit function.
The present results fall slightly below the fluence-
fit curve for energies between approximately 30 and
70 MeV. These features relate directly to the differ-
ences observed in figure 12 over the range of thick-
nesses considered. Also shown in figure 13 are the
differential fluence data points from GOES-7 instru-
ments; these points suggest that the actual fluences
are greater at higher energies than those evaluated
from the fluence-fit function for this flare event.
Discussion of Results
Potential doses to the various organs can be esti-
mated by using each of the anatomical thickness dis-
tributions in conjunction with the dose-depth curves
calculatedfortheOctober1989event.Foreachofthe
512raysof tile thicknessdistribution,a directional
doseis log linearlyinterpolated/extrapolatedfrom
the dose:depthdata. The directionaldoseis then
integratedovera soiidangleof 41rto determinethe
total doseat thetargetpointwithin theorgan.The
resultsconsistof thedoseanddose-equivalentrates
evaluatedat specifictimesduringtheflareeventfor
variousshieldingtilicknesses.The estimateddoses
arebasedon slabgeometryshieldcalculationscou-
pledwith theCAM and CAF thickness distributions
(figs. 2 to 9). Figures 14(a) and 14(5) depict some
of these results with the dose variation between se-
lected times assumed to be logarithmic. The com-
parison of figures 14(a) and i4(b) with figure 10 in-
dicates that the calculated skin dose rate variation
with time is generally similar to the flux variation
with time. The thickness values of 0.5, 2.0, 5.0, and
10.0 g/cm 2 of water are selected to depict the varia-
tion of dose rate with amount of protection. The ef-
fective shielding of an extravehicular activity (EVA)
suit and a pressurized rover can be represented by
0.5 and 2.0 g/cm 2, respectively, while a 5.0 g/cm 2
thickness approximately corresponds to an Apollo-
like capsule. A larger thickness of 10.0 g/cm 2 can
represent the shielding protection of a storm shelter.
(A linear thickness (cm) is calculated by dividin_ the
density thickness (g/cm 2) by the density (g/cm _) of
the desired material.)
By integrating the dose rates of figures 14(a)
and 14(b), the cumulative skin dose and dose equiv-
alent are evaluated as shown in figures 14(c) and
i4(d), respectively. These figures can be used to
estimate the crew incurred dose during the entire
event, with the assumption of various exposure times
behind different slab shielding thicknesses. For the
October 1989 flare spectrum, the differcnce between
the dose (Cy) and the dose-equivalent (Sv) values
is relatively small. The average quality factors for
the October 1989 event, obtained by dividing the es-
timated dose-equivalent values by dose, are on the
order of 1.3 to 1.6. The cumulative dose rate curves
indicate the amount of exposure incurred in each of
the three main pulses. Most of the dose is accumu-
lated in the first day and a half of the flare episode,
with significant additional contributions at approxi-
mately day 4 and day 6. Although not investigated
here, a fractionated dose typically reduces the over-
all effects of the radiation exposure. The crew can
reduce their overall exposure by remaining in heavily
shielded areas during peak dose rate times. Simi-
larly, the dose rates and cumulative doses are shown
for the eye and BFO in figures 15 and 16.
The 30-day limits (guidelines) of table 1 are indi-
cated on cumulative dose equivalent versus time fig-
ures for the skin, eye, and BFO. To remain below the
150-cSv 30-day limit for the skin, a shielding thick-
ness of approximately 4.4 cm of water is required. To
remain below the 100-cSv eye and the 25-cSv BFO
30-day limits, shielding thicknesses of 6.0 and 8.4 cm
of water, respectively, are required. For the October
flare I the protection Of the t3FO dictates the selec-
tion of a shield thickness of at least 8.4 cm of water
to reduce the dose to all three organs below the 30-
day limits. This amount is the minimum thickness
required for this event and assumes no radiation from
other sources, for example, galactic cosmic radiation,
man-made nuclear sources, or other flare events. The
calculated protection may be strictly applicable to
sh0rt-duration missions or storm shelter protection
requirements.
A comparison of the CAM results can be made
with the earlier calculated slab estimates (ref. 15)
as shown in table 3. For the slab results, the skin
dose has been estimated as the 0-cm-depth dose and
the BFO dose is estimated as the 5-cm-depth dose.
Characteristically, the more detailed CAM calcula-
tions result in 20 to 50 percent lower doses than the
corresponding slab calculations, with the degree of
reduction dependent on the energetic particle envi-
ronment spectrum. For the October event, both the
CAM BFO and skin doses are approximately 40 to
50 percent lower than the corresponding slab esti-
mates. Thus, the estimated minimum shielding re-
quirement of approximately 12 cm of water based on
a 5-cm-depth dose can be reduced to 8.4 cm.
Table 3. Comparison of Slab and CAM Dose-Equivalent
Estimates
[Data from ref. 15]
Water shield
thickness, g/cm 2
0.5
2.0
5.0
10.0
Skin dose
equivalent, cSv
Slab CAM
2525 1132
902 426
234 127
78 46
BFO dose
equivalent, cSv
Slab CAM
205 107
142 72
78 41
35 19
The cumulative dose and dose equivalent were cal-
culated for the other organs of figures 2 through 9.
Sample calculations of the male thyroid, male right
lung, and female right breast are illustrated in fig-
ures 17, 18, and 19. The thyroid and lung are
selected as example calculations because of the
greater risk of cancer induction to these specific or-
gans. The dose rate and cumulative dose curves are
very similar in nature for all organs considered. Ta-
bles 4 to 7 list the cumulative dose and dose equiva-
lent for the other organs protected by various shield-
ing thicknesses. With these values, some of the possi-
ble effects of this flare to exposed crew members can
be assessed.
Table 4. Cumulative Dose (cGy) Incurred for October 1989
Flare for Various W'ater Shield Thicknesses Calculated
With CAM Model Organ Distributions
Location
Eye
Skin
BFO
Thyroid
Right hmg
Esophagus
Stomach
Intestine
Liver
Pancreas
Right kidney
Bladder
Right testicle
Cumulative dose, cGy, for shield
thickness
0.5 cm 2.0 cm
599 253
721 298
80 55
361 160
53 40
207 107
27 21
56 42
32 25
31 24
41 31
42 28
150 84
of--
5.0 cm 10.0 cm
93 35
96 35
31 15
66 26
25 12
51 21
14 8
25 13
16 9
16 8
19 10
17 9
41 17
Table 5. Cumulative Dose Equivalent (cSv) Incurred for
October 1989 Flare for Various Water Shield Thicknesses
Calculated With CAM Model Organ Distributions
Cumulative dose equivalent, cSv, for
shield thickness of--
Location
Eye
Skin
BFO
Thyroid
Right hmg
Esophagus
Stomach
Intestine
Liver
Pancreas
Right kidney
Bladder
Right testicle
0.5 cm
914
1132
107
538
70
297
36
75
43
41
54
58
210
2.0 cm 5.0 cm 10.0 cm
354 123 46
426 127 46
72 41 20
220 87 34
53 33 17
144 67 28
28 19 11
56 34 17
33 22 12
32 21 12
41 26 14
38 22 12
112 54 23
Table 6. Cumulative Dose (eGy) Incurred for October 1989
Flare for Various Water Shield Thicknesses Calculated
With CAF Model Organ Distributions
Location
Breast
Right ovary
Uterus
Thyroid
Right lung
Stomach
0.5 cm
Cumulative dose, cGy, for shield
thickness o_
2.0 cm 5.0 cm I 10.0 cm
133 64 t 26
32 20 1 11
30 19 I 10
163 67 I 26
44 27 I 13
24 16 I 9
242
42
39
367
59
31
Table 7. Cumulative Dose Equivalent (eSv) Incurred for
October 1989 Flare for Various Water Shield Thicknesses
Calculated With CAF Model Organ Distributions
Cumulative dose equivalent, cSv, for
shield thickness of
Location
Breast
Right ovary
Uterus
Thyroid
Right lung
Stomach
0.5 cm
337
55
52
547
78
41
2.0 cm 5.0 cm 10.0 cm
178 84 34
43 27 14
40 26 14
224 89 35
59 36 18
32 21 12
For large solar flare exposures, some early effects
(evaluated in terms of Gy) can include the possibility
of death, vomiting, or skin irritation. The dose to the
BFO, used here to estimate whole-body exposure,
is predicted to be between 15 and 80 cGy for 10.0
to 0.5 cm of water shielding, respectively. The
risk of death or vomiting is unlikely, with the dose
cstimates below threshold values for such responses.
In most instances, an early response of the skin is
also unlikely. However, if a crew member were on
extended or frequent EVA's (_0.5 g/cm 2) during the
peak dose rate periods, a skin dose of 450 cGy could
be incurred; such a dose would produce erythema in
approximately 10 percent of individuals exposed.
Late effects (evaluated in terms of Sv) can include
the risk of lens opacification, impairment of fertil-
ity, and cancer induction. Late effects can occur a
few months to years following exposure. For crew
members protected by 2.0 to 5.0 cm of water, a dose
to the eye of 350 to 100 cSv is estimated and may
cause minimal stationary opacities. However, if the
crew member were on extended or frequent EVA's
(_0.5 g/cm 2) during the high dose rate periods, a
dose to the eye of almost 600 cSv (fig. 14(d)) could
be possible, thus the risk of some degree of lens opaci-
fication would be significantly increased. The male is
much more susceptible to fertility impairment than
the female. With the estimated dose to the ovaries
between 14 cSv and 55 cSv, the female is unlikely
to have any long-term effects on fertility. However,
for the shielding thicknesses examined, the estimated
dose to a male testicle is between 23 cSv and 210 cSv.
With these doses, the male is likely to have a de-
creased sperm count with temporary sterility lasting
between 10 to 20 months. The risk of cancer in-
duction and mortality is examined in the following
section.
The potential dose equivalents estimated for the
October 1989 event (tables 5 and 7) can be com-
pared with several organ doses predicted for the
August 1972 event as shown in table 8. In general,
Table 8. Predicted Dose Equivalent (cSv) Incurred for
August 1972 Flare for Various Water Shield
Thicknesses Calculated With CAM and
CAF Model Thickness Distributions
Location
Skin
Eye
CAM BFO
model Thyroid
Right lung
Stomach
Bree_st
CAF Thyroid
model Right lung
Stomach
! Dose equivalent, cSv, for water
! shield thickness of
0.5cm 2.0cm 5.0cm 10.0cm
1953 i 879
1673 758
187 110
1024 471
97 64
36 25
1054 371
1042 480
112 74
44 31 ] 16
I
233
217
46
144
31 i
14
130
148
35
53
51
15
36
11
6
35
37
12
6
the August 1972 dose-equivalent values are sub-
stantially larger than corresponding values for the
October 1989 event for smaller shield layers. How-
ever, as shield thickness increases, the differences
decrease and eventually the trend is reversed with
larger doses predicted for the October 1989 event.
This behavior can be explained by examining the
fluence spectra of figure 1, which shows that the Au-
gust 1972 proton fluence for energies between approx-
imately 10 and 150 MeV exceeds that of the 1989
flare by as much as a factor of 2 near 60 MeV. Be-
cause the range of 60: MeV :protons in water is ap-
proximately 3 cm, most of the contribution to the
dose equivalent is due to primary protons in this in-
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termediate energy range. A proton range of 10 cm
corresponds approximately to an energy of 150 MeV,
which is approximately where the October 1989 in-
tegral fluence exceeds that of the 1972 flare. Accord-
ingly, target points (or organ locations) within the
body show more sensitivity to lower and medium en-
ergy protons with increasing proximity to the body
surface. Thus, differences in the incurred dose equiv-
alents are larger between the two flares for the skin,
thyroid, and breast than for the BFO and stomach,
which have inherently more shielding. For exam-
ple, compare the thickness distributions for the CAF
model stomach (50-percent thickness greater than
10 cm, fig. 9) and the breast (50-percent thickness
less than 3 cm, fig. 8).
Risk Assessment
The lifetime excess risk of cancer incidence and
mortality can be estimated with the doses predicted
for the various organs. The risk analysis presented
here is based on the approach described by the
National Council on Radiation Protection and Mea-
surement (ref. 3). The risk of cancer incidence is
estimated by the NCRP using radioepiderfliological
tables developed by the National Institutes of Health
(NIH) ad hoc working group (ref. 18). Sufficient in-
formation on which to base age and gender-related
risk of cancer from radiation exposure was found for
the lung, breast, esophagus, stomach, colon, liver,
pancreas, kidney and bladder, all acute leukemias,
and chronic granulocytic leukemia. Risk estimates
for "other sites" were derived in a similar man-
ner by using Biological Effects of Ionizing Radiation
(BEIR) (ref. 19) risk estimates and the NIH work-
ing group approach. The other sites include tumors
of the oral cavity, rectum, gallbladder, uterine cor-
pus, uterine cervix, ovary, brain, bone, connective
tissue, prostate, and testis. Risk estimates for inci-
dence of melanoma, lymphoma, and Hodgkin's dis-
ease arc also included. A linear-quadratic model, in
which a linear component dominates at low doses and
a quadratic component dominates at high doses, was
used for all sites except for the breast and thyroid,
for which a linear relationship where the effects are
assumed proportional to dose was used. The can-
cer mortality risk coefficients were estimated by the
NCRP using data from the National Institutes of
Cancer Surveillance, Epidemiology, and End Results
(SEER) program. 1 Many assumptions, constraints,
and sources of uncertainty are built into the develop-
ment of radiation risk coefficients; however, the risk
1 National Cancer Institute Monogram 57 Report: Surveillance,
Epidemiology and End Results: Incidence and Mortality Data, 1973
1977. (NIH publ. no. 81-2330.)
projections are based on the best estimates available
at the time and are considered to be conservative
for space radiation exposure (ref. 3). A discussion of
the studies and their shortcomings used to interpret
radiation-induced cancer data is included in chap-
ter 5 of reference 3.
Tables of predicted excess lifetime cancer inci-
dence and mortality among 1000 persons are pre-
sented in reference 1 for either acute (>5 cCy/day) or
protracted (<5 cGy/day) radiation exposures. The
tables include projected risks for men and women ex-
posed to ionizing radiation at ages 25, 35, 45, and 55.
Lifetime cancer risks for dose exposures other than
those listed in the NCRP tables (Dtable) can be eas-
ily estimated for the new dose D of interest. The
new risks (RISK) for an acute exposure are calcu-
lated with the linear-quadratic relationship
RISK = RISKtable [D(1 + D/1.16)]
Dtable(1 + Dtable/l.16)
for all sites except the breast and thyroid where the
linear relationship
RISK --- RISKtabi e(D/Dtable)
is used. The dose D is in units of Gy, and 1.16 Gy
represents the point at which the squared dose con-
tribution is assumed to equal the linear dose contri-
bution. An acute exposure is assumed by the NCRP
to be an exposure of greater than 5 cGy/day. The
risks presented by NCRP are predicted for exposure
to sparsely ionizing radiation such as x or gamma
rays. Due to the higher LET with quality factors
greater than 1 for the October 1989 spectrum, the
dose-equivalent values (cSv) are used to estimate risk
instead of dose (cGy) values for the late carcinogenic
effect.
The October 1989 event delivers an acute dose
equivalent, defined here as greater than 5 cSv/day,
to the organs for the various shielding thicknesses.
The instantaneous dose-equivalent rates evaluated as
a function of time during the course of the flare are
used to compute corresponding dose incurred over
a 1-day interval. Figures 20 and 21 illustrate the
daily dose-equivalent variation for the CAM BFO
and stomach distributions, respectively, as obtained
by performing the 24-hour running time integration
of the corresponding dose rate functions (fig. 16(b)
for the BFO and similar data for the stomach). Each
dose-equivalent value in figures 20 and 21 represent,
at a given time, the cumulative exposure value over
the previous 24 hours. Also indicated are the times
during the flare at which the dose equivalents to
the BFO and stomach are in excess of 5 cSv. For
even 10.0 cm of water protection, the 5 cSv value
is exceeded during the initial phase of the flare for
both the BFO and the stomach. Based on the 24-
hour integral dose for the stomach, which has the
lowest cumulative dose equivalent (table 5) of the
organs considered, an acute exposure is assumed for
the October 1989 flare. The associated risks using
this assumption are conservative, because the dose is
fractionated (allowing time for repair) and the low
dose rate contributions (Dose rate < 5 cGy/day) are
assumed to be acute.
Predicted excess cancer incidences and mortalities
are presented for the male astronaut exposed to the
1989 event in tables 9 to 12 for various shield thick-
nesses. The risk of total cancers from the flare as well
as the risk of cancer to specific organs are shown. The
BFO dose equivalent was used to estimate the risk
of all acute leukemia and the risk of chronic gran-
ulocytic leukemia as well as the risk to other sites.
The intestine dose equivalent was used to estimate
the dose equivalent to the colon. Table 13 shows
the baseline lifetime expected cancer incidences and
deaths per 1000 males by age (ref. 3). From table 9, a
25-year-old male with 0.5 cm of shielding would have
a 6.28-percent increased chance of obtaining cancer
and a 3.4-percent increased chance of dying from can-
cer. This value can be compared with his overall ex-
pected risk of cancer incidence and mortality from
"natural" causes of 34.9 percent and 18.4 percent,
respectively, as shown in table 13. For a 35-year-old
male astronaut in a moderately shielded spacecraft of
5.0 cm of water, an increased risk of cancer incidence
and mortality would be 0.98 percent and 0.6 percent,
respectively. The use of a storm shelter of 10.0 cm
water for the duration of the October event reduces
the excess risk of total cancers to less than 1 percent
for male astronauts of ages greater than 25 years old.
The overall risk of cancer to females appears
greater because of a greater female sensitivity to
radiation-induced cancers of the breast and thy-
roid. The estimated lifetime risk of excess cancer
for the female breast and thyroid is shown in ta-
ble 14 for exposure to the October 1989 flare. For a
lightly shielded spacecraft, a 25-year-old female has a
greater than 5-percent increased risk of breast cancer.
These values can be compared with the baseline life-
time expected cancer incidences and deaths shown in
table 15 (ref. 3), where a 25-year-old female has a
baseline incidence risk of close to 10 percent. Over-
all, the projected risks presented in tables 9 to 14
can be used to assess some of the late effects that an
exposure to such an event can cause.
Table 9. Predicted Lifetime Risk of Excess Cancer Incidence and Mortality Among 1000 Males for
October 1989 Flare With a Water Shield Thickness of 0.5 cm
Type of cancer
Thyroid .............
Lung ..............
Esophagus ............
Stomach .............
Colon ..............
Liver ..............
Pancreas .............
Kidney and bladder ........
All acute leukemia ........
Chronic granulocytic leukemia . . .
All other cancers .........
Total cancer ........... I
Excess risk of lifetime cancers per 1000 males first exposed at age, yr--
25
Incidence Mortality Incidence
13.45 2.15 8.61
10.44 8.27 7.03
6.81 5.84 2.92
2.30 1.61 1.17
5.00 2.61 2.27
2.50 2.39 0.81
1.63 1.53 0.77
2.33 0.75 1.28
2.84 2.46 3.03
1.51 0.95 1.70
14.01 5.49 6.25
62.84 34.05
35 45 55
Mortality Incidence Mortality Incidence Mortality
1.61
5.58
2.92
0.83
1.25
0.81
0.72
0.45
2.65
0.95
2.46
35.84 iI 20.23
5.92 1.08
5.06 4.03
1.95 1.95
0.74 0.52
1.25 0.68
0.38 0.38
0.46 0.46
0.83 0.30
3.41 3.03
1.70 0.95
3.41 1.33
25.i1 14.70
3.23
3.72
2.92
0.69
1.25
0.22
0.51
0.60
3.60
1.70
2.65
21.10
0.54
2.89
1.95
0.52
0.68
0.22
0.46
0.23
3.03
0.95
1.14
"t 12.61
Table 10. Predicted Lifetime Risk of EXcess Cancer Incidence and Mortality Among 1000 Males for
October 1989 Flare With a Water Shield Thickness of 2.0 cm
Type of cancer
Thyroid .............
Lung ..............
Esophagus ............
Stomach .............
Colon ..............
Liver . : ............
Pancreas .............
Kidney and bladder ........
All acute leukemia ........
Chronic granulocytic leukemia . . .
All other cancers .........
Total cancer ...........
Excess risk of lifetime cancers per 1000 males first exposed at age, yr--
25 [ 35
Incidence Mortality tIncidence Mortality
5.50 0.88 | 3.52 0.66
7.18 5.69 l 4.83 3.84
2.08 1.78 | 0.89 0.89
1.70 1.18 " 0.86 0.61
55
45 Incidence Mortalit_Incidence Mortality
3.36
1.80
1.20
1.54
1.61
0.86
7.95
34.77
1.76
1.72
1.13
0.50
1.40
0.54
3.12
19.68
1.53
0.59
0.56
0.84
1.72
0.97
3.55
19.86
0.84
0.59
0.53
0.30
1.50
0.54
1.40
11.69
2.42
3.48
0.59
0.54
0.84
0.27
0.34
0.54
1.93
0.97
1.93
I 13.87
0.44
2.77
0.59
0.38
0.46
0.27
0.34
0.20
1.72
0.54
0.75
8.47
1.32 0.22
2.56 1.99
0.89 0.59
0.51 0.38
0.84 0.46
0.16 0.16
0.38 0.34
0.40 0.I5
2.04 1.72
0.97 0.54
1.50 0.64
11.56 7.19
i
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Table11.PredictedLifetimeRiskofExcessCancer Incidence and Mortality Among 1000 Males for
October 1989 Flare With a Water Shield Thickness of 5.0 cm
Type of cancer
Thyroid .............
Lung ..............
Esophagus ............
Stomach .............
Colon ..............
Liver ..............
Pancreas .............
Kidney and bladder ........
All acute leukemia ........
Chronic granulocytic leukemia . .
All other cancers .........
Total cancer ...........
Excess risk of lifetime cancers per 1000 males first exposed at age, yr
25 35 45 55
Incidence Mortality Incidence Mortality Incidence Mortality Incidence Mortality
2.17
3.94
0.68
1.08
1.78
1.I1
0.73
0.86
0.77
0.41
3.78
17.31
0.35 1.39
3.12 2.65
0.58 O.29
0.75 0.55
0.93 0.81
1.06 0.36
0.69 O.34
0.28 0.47
0.66 0.82
O.26 0.46
1.48 1.69
10.16 9.83
0.26
2.11
0.29
0.39
0.96 0.17
1.91 1.52
0.19 0.19
0.35 0.24
0.45 0.45 0.24
0.36 0.17 0.17
0.32 0.21
0.17 0.30
0.72 0.92
0.26 0.46
0.66 O.92
5.97 6.83
0.52
1.40
0.29
0.33
0.45
0.10
0.21 0.23
0.11 0.22
0.82 0.97
0.26 0.46
0.36 0.72
4.29 5.68
0.09
1.09
0.19
0.24
0.24
0.10
0.21
0.08
0.82
0.26
0.31
3.63
Table 12. Predicted Lifetime Risk of Excess Cancer Incidence and Mortality Among 1000 Males for
October 1989 Flare With a Water Shield Thickness of 10.0 cm
Type of cancer
Thyroid .............
Lung ..............
Esophagus ............
Stomach .............
Colon ..............
Liver ..............
Pancreas .............
Kidney and bladder ........
All acute leukemia ........
Chronic granulocytic leukemia . . .
All other cancers .........
Total cancer ...........
Excess risk of lifetime cancers per 1000 males first exposed at age, yr--
25 35 45 55
Incidence tMort ality I_ncidence IMortalitylIncidence IMortality ]Incidence ]Mort ality
0.85 I 0.14 0.54 I 0.10 0.37 0.07 I 0.20 0.03
1.81 I 1.44 1.22 I 0.97 0.88 0.70 I 0.65 0.50
0.22 ] 0.19 0.10 I 0.10 0.06 0.06 I 0.10 0.06
0.59 ] 0.41 0.30 ] 0.21 0.19 0.13 I 0.18 0.13
0.79 I 0.41 0.36 [ 0.20 0.20 0.11 I 0.20 0.11
0.56 [ 0.54 0.18 [ 0.18 0.09 0.09 I 0.05 ! 0.05
0.39 I 0.37 0.18 l 0.17 i 0.11 0.11 l 0.12 ; 0.11
0.42 I 0.14 0.23 ! 0.08 : 0.15 0.05 I 0.11 1 0.04
0.32 ] 0.28 0.35 [ 0.30 0.39 0.35 I 0.41 i 0.35
0.17 ] 0.11 0.19 I 0.11 0.19 : 0.11 [ 0.19 : 0.11
1.60 ] 0.63 0.71 I 0.28 : 0.39 __ 0.15 [ 0.30 I 0.13
7.73 I 4.64 4.37 l 2"70 I 3"02 i 1"93 i 2"51 [ 1.62
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Table13.BaselineExpectedCancerIncidences and Mortalities per 1000 Male Population by Age
[Data from NCRP-98 (ref. 3)]
Type of cancer
Thyroid .............
Lung ..............
Esophagus ............
Stomach .............
Colon ..............
Liver ..............
Pancreas .............
Kidney and bladder ........
All acute leukemia ........
Chronic granulocytic leukemia . .
All other cancers .........
Total cancer ...........
Expected cancer risks per 1000 males by age, yr--
25 35 45 55
Incidence Mortality Incidence Mortality Incidence Mortahty Incidence Mortality
1.97 0.31
72.22 57.07
5.36 4.82
12.87 9.00
35.35 18.86
2.82 2.73
10.91 10.13
32.67 10.19
5.15 4.47
1.58 0.96
168.25 66.22
349.15 184.77
- i7a 0.28
73.63 58.19
5.47 4.91
13.09 9.16
35.94 19.17
2.85 2.76
11.11 10.32
33.16 10.34
5.05 4.39
1.53 0.93
168.51 66.33
352.09 186.78
1.43 0.23 1.11 0.18
74.78 59.10 72.58 57.36
5.56 4.99 5.35 4.81
13.28 9.29 13.28 9.29
36.57 19.51 37.28 19.88
2.89 2.80 2.85 2.76
11.32 10.51 11.31 10.50
33.50 10.44 33.24 10.37
4.98 4.32 4.92 4.27
1.48 0.90 1.46 0.89
169.38 66.67 170.16 66.97
355.16 188.76 353.53 187.27
Table 14. Predicted Lifetime Risk of Excess Cancer Incidences and Mortalities Among 1000 Females for October 1989 Flare
Type of cancer
Thyroid ....
Breast .....
Water shield
thickness, cm
0.5
2.0
5.0
10.0
0.5
2.0
5.0
10.0
Excess risk of lifetime cancers per 1000 females first exposed at age, yr--
25
Incidence
42.12
17.25
6.85
2.70
105.14
55.54
26.21
10.61
35
Mortaiity - i_nce I Mortality
3.83
1.57
0.62
0.25
30.09 2.74
12.32 1.12
4.90 0.44
1.93 0.18
64.70 20.56
34.18 10.86
16.13 5.12
6.53 2.07
Incidence
21.88
8.96
3.56
1.40
11.46
6.05
2.86
1.16
33.36
17.62
8.32
3.37
45
!Mortality
2.19
0.90
0.36
0.14
3.71
1.96
0.92
0.37
55
Incidence Mortality
14.77 1.64
6.05 0.62
2.40 0.27
0.95 0.11
5.73 1.68
3.03 0.89
1.43 0.42
0.58 0.17
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Table 15. Baseline Lifetime Expected Cancer Incidences
and Mortalities per 1000 Female Population
[Data from NCRP-98 (ref. 3)]
Type of
cancer
Thyroid ....
Breast .....
Age, yr
25
35
45
55
25
35
45
55
Risk of Risk of
incidence mortality
4.74 0.43
3.88 0.35
2.99 0.27
2.20 0.20
96.12 30.52
95.26 30.25
88.97 28.25
75.13 23.85
Currently, space radiation-exposure limits are es-
tablished for LEO operations by the NCRP. The
BFO limits are selected to maintain the expected ex-
cess lifetime risk of fatal cancer to 3 percent. The
BFO dose limits are considered representative of the
minimum dose required to produce the 3-percent in-
creased risk. With larger doses anticipated for ex-
ploratory missions, regulatory commissions may wish
to consider expanding limits (from ocular lens, skin,
and BFO) to include specific limits for other organs
that exhibit high radiosensitivity (e.g., lung, thyroid,
and breast). Including new limits such as these may
be especially important if mixed crews including fe-
male astronauts are considered for future lunar and
Mars missions.
= Concluding Remarks
With future exploratory class and long-duration
missions outside of the Earth's magnetosphere, radia-
tion exposure to crew members is likely to be greater
than previously experienced. Thus, crew members
- should be aware of their risks of both short- and long-
1
term health effects. The capability to determine the
doses incurred to the skin, eye, and BFO through use
of computerized anatomical models allows a more ac-
curate prediction of the radiation exposure compared
with the more conservative 0-cm- and 5-cm-depth
i
slab doses. In addition to the skin, eye, and BFO
in which current "guidelines" are established, each
organ exhibits its own radiosensitivity based on can-
cer induction and mortality that is reflected in its
corresponding risk coefficients. The ability to pre-
dict the dose incurred to the various other organs
through use of detailed thickness distributions is im-
portant when considering the effects of radiation; for
example, the lung and the breast appear to be two of
the most sensitive organs. The thyroid also exhibits
greater cancer risks due to both its relatively light
body self-shielding and its greater radiosensitivity.
Specific measures can be implemented to mini-
mize astronaut risk due to the exposure from flares
such as the October 1989 type in which flux inten-
sities vary by many orders of magnitude over sev-
eral days. This temporal behavior of the proton
flux emphasizes the need for active real-time mon-
itoring of the flux intensity with dosimetric instru-
mentation capable of measuring dose incurred due
to deposition of energy in several spectral regions.
Such active dosimeters can indicate those times dur-
ing the flare period that essential crew maintenance
activities can be performed under relatively safe
conditions. Additionally, spacesuits or other pro-
tective apparel can be designed with shield inserts
specifically placed to give added protection to radio-
sensitive areas with relatively little body self-
shielding, such as the male reproductive organs,
female breast, thyroid, and bone marrow concen-
trations close to the body surface (pelvic bones,
sternum).
NASA Langley Research Center
Hampton, VA 23681-0001
July 30, 1992
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Appendix
Hourly Averaged integral Fluxes for October 1989 Event
Table A1. Hourly Averaged Integral Fluxes at Selected Times During Data Period Used To Calculate
Integral Fluence Time Variation at Each Energy
[Data from ref. 7]
Time Hourly average integral fluxes (protons/cm2-sec-sr) for E I > E, MeV
Day Hour
Oct. 19 06 3.49 x 10 °
Oct. 19 13 2.75 x 101
Oct. 19 20 3.10 x 103
Oct. 20 04 7.29 x 103
Oct. 20 11 2.09 x i04
Oct. 20 15 1.86 x 105
Oct. 21 01 2.57 × 104
Oct. 22 17 1.00 x 103
Oct. 22 19 2.59 x 103
Oct. 23 04 1.19 × 104
Oct. 24 16 1.99 x 103
Oct. 25 00 5.08 x 103
Oct. 26 16 6.04 x 103
Oct. 29 04 7.76 x 101
E> 1 E>5 E> 10 E>30 E>50 E>60 E> 100
3.36 x 10 -1
2.36 x 101
1.68 x 103
4.32 x 103
7.66 x 103
8.01 x 104
7.80 x 103
3.81 x 102
1.16x 103
4.95 x 103
6.30 x 102
2.95 x 103
6.83 x 102
1.62 x 101
1.33x I0-I
2.36x 101
1.07x 103
2.41 x 103
2.96 x 103
3.84 x 104
3.51 x 103
1.75 x 102
9.32 x 102
3.61 x 103
3.07 x 102
2.12 x 103
2.56 x 102
7.44 x 10 o
6.50 x 10 -2
2.35 x 101
5.60 x 102
8.02 x 102
6.53 x 102
7.15 x 103
6.39 x 102
2.66 x 101
5.46 x 102
1.22 x 103
6.05 x 101
6.96 x 102
4.66 x 101
1.86 x 100
4.70 x 10 -2
2.24 x 101
3.82 x 102
4.47 x 102
3.17 x 102
2.55 x 103
2.29 x 102
8.44 x 10 °
3.67 x 102
5.41 × 102
2.18 x l0 t
3.45 x 102
1.94 x 101
9.32 x 10-1
4.02 x 10 -2
2.12 x 101
3.17 x 102
3.50 x 102
2.39 x 102
1.61 x 103
1.43 x 102
4.99 x 100
2.99 x 102
3.58 x 102
1.33 x 101
2.57 x 102
1.36 x 101
7.00x 10-I
2.09 x 10-2
1.24 x lOI
1.69 x 102
1.69 x 102
1.06 x 102
4.93 x 102
4.30 x lOI
1.39x I0°
1.54x 102
1.20x 102
3.87 x 10 °
1.17 x 102
5.52 x 10 °
3.16 x 10 -1
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Figure 1. Integral fluence as a function of energ_ for four large proton flares.
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Figure 2. CAM model water thickness distributions for skin, eye, and BFO.
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Figure 3. CAM model water thickness distributions for four separate points within the thyroid and directional-
averaged thyroid distribution.
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Figure 4. Comparison of CAM and CAF average thyroid water thickness distributions.
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Figure 5. CAM model water thickness distributions for esophagus, intestine, and stomach.
100-
90- .._
8o- / /_ .
70 - Average ! /_ Pancreas
right / / -
Percent 60- lung//thickness 5 -
(t 4 0 - / /_ ILiver
30-
20- //i///10-
0 .... , ' ' _t'/'7"' ' ' ,,., , ,,,l
loO lo 1 lo2
Tissue thickness, t, cm
Figure 6_. CAM model water thickness distribution s for right lung, liver, and pancreas.
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Figure 7. CAM model water thickness distributions for right testicle, right kidney, and bladder.
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Figure 8. CAF model water thickness distributions for right breast, ovary, and uterus.
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Figure 9. CAF model water thickness distributions for right lung and stomach.
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Figure 10. Hourly averaged integral flux history for October 1989 solar flare event. (GOES-7 data from NOAA
Space Environment Laboratory, ref. 7.)
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Figure 11. Cumulative differential fluence for October 1989 flare event at selected times.
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Figure 13. Comparison of differential fluence as a function of energy for the NOAA rigidity fit versus 10-day
time-integrated fluence.
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Figure 14. Predicted skin dose rate variation and cumulative dose during October 1989 event with 0.5, 2.0,
5.0, and 10.0 cm of water shield thickness.
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Figure 15. Predicted eye dose rate variation and cumulative dose during October 1989 event with 0.5, 2.0, 5.0,
and 10.0 cm of water shield thickness.
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Figure 16. Predicted BFO dose rate variation and cumulative dose during October 1989 event with 0.5, 2.0,
5.0, and 10.0 cm of water shield thickness.
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Figure 17. Predicted male thyroid dose-equivalent rate variation and cumulative dose equivalent during
October 1989 event with 0.5, 2.0, 5.0, and 10.0 cm of water shield thickness.
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Figure i81 Predicted male right lung dose-equivalent rate variation and cumulative dose equivalent during
October 1989 event Wlth 0.5, 2.0, 5.0, and 10.0 cm of water shield thickness.
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Figure 19. Predicted female right breast dose-equivalent rate variation and cumulative dose equivalent during
October 1989 event with 0.5, 2.0, 5.0, and 10.0 cm of water shield thickness.
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Figure 20. 24-hour cumulative dose equivalent as a function of time to BFO for October 1989 event for water
shield thicknesses of 0.5, 2.0, 5.0, and 10.0 cm.
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Figure 21. 24-hour cumulative dose equivalent as a function of time to stomach for October 1989 event for
water shield thicknesses of 0.5, 2.0, 5.0, and 10.0 cm.
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